Adeoye Y Olukotun - Net Worth and Insider Trading
Adeoye Y Olukotun Net Worth
The estimated net worth of Adeoye Y Olukotun is at least $474,098 dollars as of 2025-04-26. Adeoye Y Olukotun is the Director of Arrowhead Pharmaceuticals Inc and owns about 35,781 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $474,098. Adeoye Y Olukotun is also the Director of Tonix Pharmaceuticals Holding Corp and owns about 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) stock worth over $0. Details can be seen in Adeoye Y Olukotun's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Adeoye Y Olukotun has not made any transactions after 2025-01-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Adeoye Y Olukotun
Adeoye Y Olukotun Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Adeoye Y Olukotun owns 4 companies in total, including Arrowhead Pharmaceuticals Inc (ARWR) , Tonix Pharmaceuticals Holding Corp (TNXP) , and VIA Pharmaceuticals Inc (VIAP) among others .
Click here to see the complete history of Adeoye Y Olukotun’s form 4 insider trades.
Insider Ownership Summary of Adeoye Y Olukotun
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ARWR | Arrowhead Pharmaceuticals Inc | 2025-01-23 | director |
| TNXP | Tonix Pharmaceuticals Holding Corp | 2020-08-13 | director |
| VIAP | VIA Pharmaceuticals Inc | 2007-12-17 | Chief Medical Officer |
 | | 2022-02-14 | Chief Executive Officer |
Adeoye Y Olukotun Latest Holdings Summary
Adeoye Y Olukotun currently owns a total of 2 stocks. Among these stocks, Adeoye Y Olukotun owns 35,781 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of January 23, 2025, with a value of $474,098 and a weighting of 100%. Adeoye Y Olukotun also owns 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) as of August 13, 2020, with a value of $0 and a weighting of 0%.
Latest Holdings of Adeoye Y Olukotun
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARWR | Arrowhead Pharmaceuticals Inc | 2025-01-23 | 35,781 | 13.25 | 474,098 |
| TNXP | Tonix Pharmaceuticals Holding Corp | 2020-08-13 | 0 | 17.82 | 0 |
Holding Weightings of Adeoye Y Olukotun
Adeoye Y Olukotun Form 4 Trading Tracker
According to the SEC Form 4 filings, Adeoye Y Olukotun has made a total of 5 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 959 shares on January 23, 2025, which brought Adeoye Y Olukotun around $20,139.
According to the SEC Form 4 filings, Adeoye Y Olukotun has made a total of 1 transactions in Tonix Pharmaceuticals Holding Corp (TNXP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tonix Pharmaceuticals Holding Corp is the acquisition of 0 shares on August 13, 2020, which cost Adeoye Y Olukotun around $5,029.
Insider Trading History of Adeoye Y Olukotun
- 1
Adeoye Y Olukotun Trading Performance
GuruFocus tracks the stock performance after each of Adeoye Y Olukotun's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Adeoye Y Olukotun is -45.8%. GuruFocus also compares Adeoye Y Olukotun's trading performance to market benchmark return within the same time period. The performance of stocks bought by Adeoye Y Olukotun within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Adeoye Y Olukotun's insider trading performs compared to the benchmark.
Performance of Adeoye Y Olukotun
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -33.33 | | | | | |
| Relative Return to S&P 500(%) | -32.37 | | | | | |
Adeoye Y Olukotun Ownership Network
Ownership Network List of Adeoye Y Olukotun
Ownership Network Relation of Adeoye Y Olukotun
Adeoye Y Olukotun Owned Company Details
What does Arrowhead Pharmaceuticals Inc do?
Who are the key executives at Arrowhead Pharmaceuticals Inc?
Adeoye Y Olukotun is the director of Arrowhead Pharmaceuticals Inc. Other key executives at Arrowhead Pharmaceuticals Inc include director & President and CEO Christopher Richard Anzalone , CFO Kenneth Allen Myszkowski , and General Counsel Patrick O'brien .
Arrowhead Pharmaceuticals Inc (ARWR) Insider Trades Summary
Over the past 18 months, Adeoye Y Olukotun made 2 insider transaction in Arrowhead Pharmaceuticals Inc (ARWR) with a net sale of 3,809. Other recent insider transactions involving Arrowhead Pharmaceuticals Inc (ARWR) include a net sale of 622,793 shares made by Christopher Richard Anzalone , a net sale of 85,112 shares made by James C Hamilton , and a net sale of 101,271 shares made by Kenneth Allen Myszkowski .
In summary, during the past 3 months, insiders sold 492,547 shares of Arrowhead Pharmaceuticals Inc (ARWR) in total and bought 0 shares, with a net sale of 492,547 shares. During the past 18 months, 959,377 shares of Arrowhead Pharmaceuticals Inc (ARWR) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 956,377 shares.
Arrowhead Pharmaceuticals Inc (ARWR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arrowhead Pharmaceuticals Inc Insider Transactions
Adeoye Y Olukotun Mailing Address
Above is the net worth, insider trading, and ownership report for Adeoye Y Olukotun. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Adeoye Y Olukotun's mailing address is: Ann Arbor Mi 48108.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
